Structure-specific inhibition of cholesteryl ester transfer protein by azaphilones

Journal of Antibiotics

Volumn 52, Issue 2, 1999, Pages 160-170

  Tomoda, Hiroshi ^a,b   Matsushima, Chikako ^b   Tabata, Noriko ^a   Namatame, Ichiji ^b   Tanaka, Haruo ^b   Bamberger, Mark J ^c   Arai, Hiroyuki ^d   Fukazawa, Masayoshi ^d   Inoue, Keizo ^d   Omura, Satoshi ^a,b  

^a KITASATO INSTITUTE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c PFIZER INC   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHAETOVIRIDIN A; CHAETOVIRIDIN B; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; KETONE; LYSINE; PROTEIN INHIBITOR; ROTIORIN; RUBROROTIORIN; SCLEROTIORIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; COVALENT BOND; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0032982826     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.52.160     Document Type: Article

References (44)

1. TALL, A. R.; Plasma cholesteryl ester transfer protein. J. Lipid Res. 34: 1255-1274, 1993
2. BARTER, P. & K.-A. RYE: Cholesteryl ester transfer protein: its role in plasma lipid transport. Clin. Exp. Pharmacol. Physiol. 21: 663-672, 1994
3. LAGROST, L.; Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim. Biophys. Acta 1215: 209-236, 1994
4. HESLER, C. B.; T. L. SWENSON & A. R. TALL: Purification and characterization of a human plasma cholesteryl ester transfer protein. J. Biol. Chem. 262: 2275-2282, 1987
5. JARNAGIN, A. S.; W. KOHR & C. FIELDING: Isolation and specificity of a Mr 74,000 cholesteryl ester transfer protein from human plasma. Proc. Natl. Acad. Sci. USA 84: 1854-1857, 1987
6. DRAYNA, D.; A. S. JARNAGIN, J. MCLEAN, W. HENZEL, W. KOHN, C. FIELDING & R. LAWN: Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 327: 632-634, 1987
7. HOPKINS, G. J.; L. B. F. CHANG & P. J. BARTER: Role of lipid transfers in the formation of a subpopulation of small high density lipoproteins. J. Lipid Res. 26: 218-229, 1985
8. AGELLON, L. B.; A. WALSH, T. HAYEK, P. MOULIN, X. C. JIANG, S. A. SHELANSKI, J. L. BRESLOW & A. R. TALL: Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J. Biol. Chem. 266: 10796-10801, 1991
9. KOIZUMI, J.; H. MABUCHI, A. YOSHIMURA, I. MICHISHITA, M. TAKEDA, H. ITOH, Y. SAKAI, T. SAKAI, K. UEDA & R. TAKEDA: Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia Atherosclerosis 58: 175-186, 1985
10. BROWN, M. L.; A. INAZU, C. B. HESLER, L. B. AGELLON, C. MANN, M. E. WHITELOCK, Y. L. MARCEL, R. W. MILNE, J. KOIZUMI, H. MABUCHI, T. TAKEDA & A. R. TALL: Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 342: 448-451, 1989
11. MAROTTI, K. R.; C. K. CASTLE, R. W. MURRAY, E. F. REHBERG, H. G. POLITES & G. W. MELCHIOR: The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism. Insights from studies with transgenic mice. Arterioscler Thromb. 12: 736-744, 1992
12. MAROTTI, K.; C. K. CASTLE, T. P. BOYLE, A. H. LIN, R. W. MURRAY & G. W. MELCHIOR: Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 364: 73-75, 1993
13. SUGANO, M.; N. MAKINO, S. SAWADA, S. OTSUKA, M. WATANABE, H. OKAMOTO, M. KAMADA & A. MIZUSHIMA: Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits. J. Biol. Chem. 273: 5033-5036, 1998
14. BISGAIER, C. L.; A. D. ESSENBURG, L. L. MINTON, R. HOMAN, C. J. BLANKLEY & A. WHITE: Cholesteryl ester transfer protein inhibition by PD 140195. Lipids 29: 811-818, 1994
15. EPPS, D. E.; K. A. GREENLEE, J. S. HARRIS, E. W. THOMAS, C. K. CASTLE, J. F. FISHER, R. R. HOZAK, C. K. MARSCHKE, G. W. MELCHIOR & F. L. KEZDY: Kinetics and inhibition of lipid exchange catalyzed by plasma cholesteryl ester transfer protein (lipid transfer protein). Biochemistry 34: 12560-12569, 1995
16. KOTHARI, H. V.; K. J. POIRIER, W. H. LEE & Y. SATOH: Inhibition of cholesterol ester transfer protein CGS 25159 and changes in lipoproteins in hamsters. Atherosclerosis 128: 59-66, 1997
17. COVAL, S. J.; M. A. CONOVER, R. MIERZWA, A. KING & M. S. PUAR: Wiedendiol-A and B, cholesteryl ester transfer protein inhibitors from the marine sponge Xestesponogia wiedenmayeni. Bioorg. Med. Chem. Lett. 5: 605-610, 1995
18. CHACKALAMANNIL, S.; Y. XIA, Y. G. WANG, H. G. TSAI, M. CZARNIECKL, S. WANG, A. CLEMMONS, H. S. AHN & G. BOYKOW: Novel inhibitors of cholesteryl ester transfer protein. Bioorg. Med. Chem. Lett. 5: 2005-2010, 1995
19. SHIN, J.; Y. SEO, J.-R. RHO, E. BAEK, B.-M. KWON, T.-S. JEONG & S.-H. BOK: Suberitenoes A and B: Sesterterpenoids of an unpreceedented skeletal class from the antarctic sponge Suberites sp. J. Org. Chem. 60: 7582-7588, 1995
20. KUO, M.Z.; R. J. ZIELINSKI, J. I. CIALDELLA, C. K. MARSCHKE, M. J. DUPUIS, G. P. LI, D. A. KLOOSTERMAN, C. H. SPILMAN & V. P. MARSHALL: Discovery, isolation, structure elucidation and biosynthesis of U-10635, a cholesteryl ester transfer protein inhibitor from UCI1136. J. Am. Chem. Soc. 117: 10629-10634, 1995
21. KIM, Y-K.; K.-H. SON, J.-Y. NAM, S.-U. KIM, T.-S. JEONG, W.-S. LEE, S.-H. BOK, B.-M. KWON, Y. J. PARK & J. M. SHIN: Inhibition of cholesteryl ester transfer protein by rosenonolactone derivatives. J. Antibiotics 49: 815-816, 1996
22. CHO, K. H.; J. Y. LEE, M. S. CHOI, J. M. CHO, J. S. LIM & Y. B. PARK: A peptide from hog plasma that inhibits human cholesteryl ester transfer protein. Biochim. Biophys. Acta 1391: 133-144, 1998
23. TAKAHASHI, F.; K. HASUMI & A. ENDO: Modulation of the plasma cholesteryl ester transfer by stachybotramide. Biochim. Biophys. Acta 1258: 70-74, 1995
24. 5Cl, a chlorine-containing metabolic product of Penicillium sclerotiorum van BEYMA. Biochem. J. 34: 1419-1421, 1940
25. FUJIMOTO, H.; T. MATSUDO, A. YAMAGUCHI & M. YAMAZAKI: Two new fungal azaphilones from Talaromyces luteus, with monoamine oxidase inhibitory effect. Heterocycles 30: 607-616, 1990
26. NAKAMURA, M.; T. KINO, J. KOJI, S. KIYOTOH & M. OKUHARA: Japan Kokai Patent H2: 255615, 1990
27. YASUKAWA, K.; M. TAKAHASHI, S. NATORI, K. KAWAI, M. YAMAZAKI, M. TAKEUCHI & M. TAKIDO: Azaphilones inhibit tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mice. Oncology 51: 108-112, 1994
28. ŌMURA, S.; H. TANAKA, H. IKEDA & R. MASUMA: Isochromophilones I and II, novel inhibitors against gp120-CD4 binding from Penicillium sp. J. Antibiotics 46: 1908-1911, 1993
29. ARAI, N.; K. SHIOMI, H. TOMODA, N. TABATA, D.-J., YANG, R. MASUMA, T. KAWAKUBO & S. ŌMURA: Isochromophilones III-VI, inhibitors of acyl-CoA:cholesterol acyltransferase produced by Penicillium multicolor FO-3216. J. Antibiotics 48: 696-702, 1995
30. LOWRY, O. H.; H. J. ROSENBROUGH, A. L. FARR & R. J. RANDALL: Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951
31. KATO, H.; T. NAKANISHI, H. ARAI, I. NISHIDA & T. NISHIDA: Purification, microheterogeneity, and stability of human lipid transfer protein. J. Biol. Chem. 264: 4082-4087, 1989
32. BRESLOW, J. L.: Transgenic mouse models of lipoprotein metabolism and atherosclerosis. Proc. Natl. Acad. Sci. USA 90: 8314-8318, 1993
33. SWENSON, T. L.; R. W. BROCIA & A. R. TALL: Plasma cholesteryl ester transfer protein has binding sites for neutral lipids and phospholipids. J. Biol. Chem. 263: 5150-5157, 1988
34. LAEMMLI, U.K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970
35. FUKAZAWA, M.; H. ARAI & K. INOUE: Establishment of anti-human cholesteryl ester transfer protein monoclonal antibodies and radioimmunoassaying of the level of cholestryl ester transfer protein in human plasma. J. Biochem. 111: 696-698, 1992
36. EADE, R. A.; H. PAGE, A. ALEXANDER, K. TURNER & W. B. WHALLEY: The chemistry of fungi. Part XXVIII. Sclerotiorin and its hydrogenation products. J. Chem. Soc. 1957: 4913-4924, 1957
37. JIANG, X. C.; C. BRUCE, T. COCKE, S. WANG, M. BOGUSKI & A. R. TALL: Point mutagenesis of positively charged amino acids of cholesteryl ester transfer protein: conserved residues within the lipid transfer/lipopolysaccharide binding protein gene family essential for function. Biochemistry 34: 7258-7263, 1995
38. KOTAKE, H.; L. B. AGELLON & S. YOKOYAMA: Modification of the N-terminal cysteine of plasma cholesteryl ester transfer protein selectively inhibits triglyceride transfer activity. Biochim. Biophys. Acta 1347: 69-74, 1997
39. SWENSON, T. L.; C. B. HESLER, M. L. BROWN, E. QUINET, P. P. TROTTA, M. F. HASLANGER, F. C. A. GAETA, Y. L. MARCEL, R. W. MILNE & A. R. TALL: Mechanism of cholesteryl ester transfer protein inhibition by a neutralizing monoclonal antibody and mapping of the monoclonal antibody epitope. J. Biol. Chem. 264: 14318-14326, 1989
40. MELCHIOR, G. W.; K. A. GREENLEE, C. K. CASTLE, M. J. PROUGH, R. W. MILNE, K. R. MAROTTI & F. J. KEZDY: Evidence that cynomolgus monkey cholesteryl ester transfer protein has two neutral lipid binding sites. J. Biol. Chem. 270: 21068-21074, 1995
41. BUSCH, S. J. & J. A. K. HARMONY: Cholesteryl ester analogs inhibit cholesteryl ester but not triglyceride transfer catalyzed by the plasma cholesteryl ester-triglyceride transfer protein. Lipids 25: 216-220, 1990
42. CONNOLLY, D. T.; D. HEUVELMAN & K. GLENN: Inactivation of cholesteryl ester transfer protein by cysteine modification. Biochem. Biophys. Res. Commun. 223: 42-47, 1996
43. SAMMETT, D. & A. R. TALL: Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis. J. Biol. Chem. 260: 6687-6697, 1985
44. NISHIDA, H. I.; H. ARAI & T. NISHIDA: Cholesterol ester transfer mediated by lipid transfer protein as influenced by changes in the charge characteristics of plasma lipoproteins. J. Biol. Chem. 268: 16352-16360, 1993